RxDoctor Payments Data

Reshma Katira, MD

Retina Specialist · Alexandria, VANPI 1700851607

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 65 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 28.8% of the total. That places this record below the midpoint for retina specialist clinicians in VA, where the typical reported total is $1,967.

$1,761in general payments, 2019–2025

Across 65 payments — averaging $27.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$508
  • Regeneron Healthcare Solutions, Inc.$258
  • Astellas Pharma US Inc$208
  • Aerie Pharmaceuticals, Inc.$116
  • Genentech USA, Inc.$111
  • Apellis Pharmaceuticals, Inc.$74
  • plus $484 from 13 others

What the payments were for

  • Food & beverage$1,761100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,761 in reported general payments places this provider in the 45th percentile of 41 retina specialist providers in Virginia.

See all retina specialist providers in Virginia

Medicare billing

Part B allowed, 2024
$4,407,995
Medicare patients
1,249
Services billed
43,528

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ProlensaBromfenac Sodium26$9,198
Bromfenac Sodium47$4,851
Prednisolone Acetate45$2,246
Brimonidine Tartrate12$1,128
Ketorolac Tromethamine32$832
Tobramycin-DexamethasoneTobramycin/Dexamethasone13$715
ErythromycinErythromycin Base24$375
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat16$337
Latanoprost11$224
MoxifloxacinMoxifloxacin Hcl13$207
Ofloxacin16$177

Paid to pharmacies, not to this prescriber.

Other retina specialist in Alexandria

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →